C. Scott

发表

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

P. Gosse, S. Oparil, Pankaj Gupta, 2022, The Lancet.

Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

B. Davis, Jackson T. Wright, P. Whelton, 2008, Archives of internal medicine.

How different pre-existing mental disorders and their co-occurrence affects clinical outcomes of COVID-19? A study based on real-world data in the Southern United States

B. Olatosi, S. Weissman, S. Qiao, 2021, medRxiv.

Diagnosis, prevention, and intervention for the metabolic syndrome.

Cranford L Scott, C. L. Scott, C. Scott, 2003, The American journal of cardiology.